People · Operator
Named in public records as an officer, director or promoter · active 2013–2021 · Biotechnology, Other Health Care, Other Technology, Other, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Femasys Inc | — | Biotechnology | Series B | $74.7M | $32.0M | 2016 |
| Heart Test Laboratories, Inc. | — | Other Health Care | Series A | $35.1M | $5.6M | 2018 |
| Prairie Gold, Inc. | — | Other Technology | Seed | $3.8M | $129.5M | 2015 |
| Best Agent Today, Inc. | — | Other Technology | Seed | $3.5M | $7.5M | 2021 |
| Sandspring Resources Ltd. | — | Other | Seed | $3.2M | $5.2M | 2014 |
| Lam Pharmaceutical Corp | — | Pharmaceuticals | Pre-Seed | $172K | $8.1M | 2013 |
John Adams at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside John Adams on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Joshua Silverman | 1 | 8 |
| Charles Larsen | 1 | 7 |
| Parker H. Petit | 1 | 5 |
| Gary Thompson | 1 | 4 |
| John Owen | 1 | 4 |
| Fred Aslan | 1 | 3 |
| David R. Wells | 1 | 3 |
| John Dyett | 1 | 3 |
| DOV ELEFANT | 1 | 3 |
| Richard Rubino | 1 | 3 |
| Jeffrey Taylor | 1 | 3 |
| Mark C. Maier | 1 | 2 |
| Jeffrey Marcus | 1 | 1 |
| Daniel Currie | 1 | 1 |
| Cheryl Yang | 1 | 1 |
| Kathy Lee-Sepsick | 1 | 1 |
| Gary Chen | 1 | 1 |
| Edward Uzialko | 1 | 1 |
| Edward R. Uzialko, Jr. | 1 | 1 |
| Edward R., Jr. Uzialko | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.